Skip to content

Pharmacological combined with mechanical prophylaxis versus pharmacological prophylaxis alone for thromboprophylaxis following minimally invasive esophagectomy: A prospective randomized controlled trial

Pharmacological combined with mechanical prophylaxis versus pharmacological prophylaxis alone for thromboprophylaxis following minimally invasive esophagectomy: A prospective randomized controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081064
Enrollment
Unknown
Registered
2024-02-21
Start date
2024-02-23
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Pharmacological prophylaxis group:Pharmacological prophylaxis alone
Pharmacological combined with mechanical prophylaxis group:Pharmacological combined with mechanical prophylaxis

Sponsors

Cancer Hospital Chinese Academy of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Resectable esophageal cancer or esophagogastric junction cancer received minimally invasive esophagectomy; 2. Age >=18 years; 3. Postoperative Caprini score >=5; 4. ECOG PS 0-1; 5. No VTE was found by ultrasonic examination before surgery.

Exclusion criteria

Exclusion criteria: 1. Bleeding > 400 mL intra-operation or chest drainage > 100 mL/h during the first 6 h after operation; 2. Patients who need to be transferred to the intensive care unit after surgery; 3. Contraindications or allergies to anticoagulants; 4. Use of anticoagulant or antiplatelet drugs within 1 week before surgery; 5. The need for prolonged use of anticoagulants; 6. Any conditions in which ultrasound or computed tomography pulmonary angiography (CTPA) were contraindicated; 7. Pregnancy or lactation; 8. History of hemorrhagic disease.

Design outcomes

Secondary

MeasureTime frame
The incidence of bleeding events after minimally invasive esophagectomy;Incidence of major complications;

Primary

MeasureTime frame
VTE incidence after MIE;

Countries

China

Contacts

Public ContactYin Li

Cancer Hospital Chinese Academy of Medical Science

liyin@cicams.ac.cn+86 139 0383 8752

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026